Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lothe

Showing results (241-250 of 286) with videos related to

Pageof 29
Sort By:
Plos Genetics|July 30, 2016
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver ResectionAnita Sveen, Inger Marie Løes, Sharmini Alagaratnam, et al.
Genes, Chromosomes & Cancer|September 11, 2012
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genesRicardo Celestino, Eva Sigstad, Marthe Løvf, et al.
Journal of Cellular and Molecular Medicine|September 12, 2014
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potentialMafalda Almeida, Vera L Costa, Natália R Costa, et al.
Epigenetics|September 18, 2012
Novel target genes and a valid biomarker panel identified for cholangiocarcinomaKim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al.
European Urology|September 6, 2018
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic HeterogeneityMarthe Løvf, Sen Zhao, Ulrika Axcrona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samplesVera L Costa, Rui Henrique, Stine A Danielsen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2018
Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53Maren Høland, Matthias Kolberg, Stine Aske Danielsen, et al.
Nature Communications|May 21, 2024
Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancerJonas Langerud, Ina A Eilertsen, Seyed H Moosavi, et al.
Genome Medicine|September 2, 2021
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneitySeyed H Moosavi, Peter W Eide, Ina A Eilertsen, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangementsPaula Paulo, Franclim R Ribeiro, Joana Santos, et al.
Pageof 29

Showing results (241-250 of 286) with videos related to

Sort By:
Pageof 29
Plos Genetics|July 30, 2016
Intra-patient Inter-metastatic Genetic Heterogeneity in Colorectal Cancer as a Key Determinant of Survival after Curative Liver ResectionAnita Sveen, Inger Marie Løes, Sharmini Alagaratnam, et al.
Genes, Chromosomes & Cancer|September 11, 2012
Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genesRicardo Celestino, Eva Sigstad, Marthe Løvf, et al.
Journal of Cellular and Molecular Medicine|September 12, 2014
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potentialMafalda Almeida, Vera L Costa, Natália R Costa, et al.
Epigenetics|September 18, 2012
Novel target genes and a valid biomarker panel identified for cholangiocarcinomaKim Andresen, Kirsten Muri Boberg, Hege Marie Vedeld, et al.
European Urology|September 6, 2018
Multifocal Primary Prostate Cancer Exhibits High Degree of Genomic HeterogeneityMarthe Løvf, Sen Zhao, Ulrika Axcrona, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2010
Three epigenetic biomarkers, GDF15, TMEFF2, and VIM, accurately predict bladder cancer from DNA-based analyses of urine samplesVera L Costa, Rui Henrique, Stine A Danielsen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 28, 2018
Inferior survival for patients with malignant peripheral nerve sheath tumors defined by aberrant TP53Maren Høland, Matthias Kolberg, Stine Aske Danielsen, et al.
Nature Communications|May 21, 2024
Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancerJonas Langerud, Ina A Eilertsen, Seyed H Moosavi, et al.
Genome Medicine|September 2, 2021
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneitySeyed H Moosavi, Peter W Eide, Ina A Eilertsen, et al.
Neoplasia (New York, N.Y.)|August 21, 2012
Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangementsPaula Paulo, Franclim R Ribeiro, Joana Santos, et al.
Pageof 29